ArticleInternational journal of inflammation2021

Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients.

Karina Karina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.